# Praxis Precision Medicines, Inc. (PRAX): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/prax for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

Praxis Precision Medicines, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to creating innovative treatments for central nervous system (CNS) conditions that stem from an imbalance in neuronal activity. The company's primary investigational compounds currently undergoing evaluation include: PRAX-114, an extrasynaptic-preferring positive allosteric modulator of the GABAA receptor, which is currently in Phase IIa clinical trials for addressing both major depressive disorder and perimenopausal depression. Additionally, PRAX-944, a small molecule designed to selecti...

## Quote & Key Metrics

As of 2026-10-23:

| Metric | Value |
|---|---|
| Price | $252.96 USD |
| Market Cap | $7.06B |
| P/E (TTM) | — |
| EPS (TTM) | −$12.93 |
| 52-Week Range | $154.45 – $392.70 |
| Dividend Yield (TTM) | — |

## Dividend

PRAX has no dividend payment history in our records.

## Frequently Asked Questions

### What does Praxis Precision Medicines, Inc. do?

Praxis Precision Medicines, Inc. (PRAX) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is PRAX's market cap?

Praxis Precision Medicines, Inc. (PRAX) has a market capitalization of approximately $7.06 billion, as of October 23, 2026, based on the most recent share price and shares outstanding.

### Does PRAX pay a dividend?

No, Praxis Precision Medicines, Inc. (PRAX) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

### Is PRAX profitable?

Praxis Precision Medicines, Inc. (PRAX) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### Has PRAX ever paid a dividend?

No. Dividend Data's records show no dividend payments from Praxis Precision Medicines, Inc. (PRAX). A first dividend would appear on the Dividend tab once it is declared.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/prax
- Dividend history & safety: https://www.dividenddata.com/stocks/prax/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/prax/earnings
- Financial statements: https://www.dividenddata.com/stocks/prax/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/prax/valuation
- Peer comparison: https://www.dividenddata.com/stocks/prax/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.